Outbreak Investigation of Lumpy Skin Disease in Dairy Farms at Barishal, Bangladesh

2020 ◽  
Author(s):  
Md. Ibrahim Khalil ◽  
Mohammad Ferdous Rahman Sarker ◽  
Yasir Hasib ◽  
sharmin chowdhury
Keyword(s):  
Skin Disease ◽  
Dairy Farms ◽  
Outbreak Investigation ◽  
Lumpy Skin Disease

scholarly journals Assessment on Economic Losses due to Animal Health and Production Constraints in Jimma Town Intensive Dairy Farms, Jimma, Ethiopia

2020 ◽  
pp. 52-60
Keyword(s):  
Skin Disease ◽  
Animal Health ◽  
Dairy Farms ◽  
Dairy Farming ◽  
Economic Losses ◽  
Financial Loss ◽  
Lumpy Skin Disease ◽  
Production Constraints ◽  
Milk Fever ◽  
Jimma Town

A single-visit-multiple subject formal survey technique was used to collect data from 75 small-scale dairy farming households which were selected at random and were interviewed using a pre-tested, semi-structured questionnaire. Seventy-three (97.3%) dairy farming was practiced under an intensive management system. Among the selected dairy farms, only (33.3%) were kept in good hygienic condition. Artificial insemination was common (69.3%) breeding system practiced in most dairy farms of studying area. This study discovered that only a few dairy farms (2.7%) undergo periodic vaccination. It appeared from the study that morbidity loss of animals was primarily caused by mastitis which calculated (42.7%), black leg (32%), lumpy skin disease (21.3%), milk fever (17.3%), heart water (10.7%) and foot rote (5.3%) in order of their decreasing order. The results of this survey revealed that mastitis was ranked as the number one disease of dairy animals while foot rote was list reported disease in the study area. Morbidity loss of production and productivity was estimated to the financial loss of (812,600 birrs) per year. Not only morbidity loss, in some farms, mortality was also common problems of the study area. Mainly common diseases such as heart water (6.7%), milk fever (5.3%), back leg (2.7%), and lumpy skin disease (1.7%) were major causes of mortality in few farms. This in turn estimated the financial loss of (625,000 birrs). Eventually, overall annual financial loss as a result of mortality and morbidity was estimated to be (1,437,600 birrs). The outbreak of lumpy skin disease and blacklegs could be controlled through improving veterinary services with respect to adequate vaccination and heart water (seasonal tick infestation) would be alleviated by spraying. The aim of the study was to assess assessment on economic losses due to animal health and production constraints in Jimma town intensive dairy farms, Jimma, Ethiopia.

scholarly journals Outbreak investigation of lumpy skin disease in dairy farms at Barishal, Bangladesh

2021 ◽  
Vol 9 (1) ◽  
pp. 205-209
Author(s):  
Md. Ibrahim Khalil ◽  
Mohammad Ferdous Rahman Sarker ◽  
F. M. Yasir Hasib ◽  
Sharmin Chowdhury
Keyword(s):  
Skin Disease ◽  
Dairy Farms ◽  
Effective Control ◽  
Morbidity Rate ◽  
Crossbred Cattle ◽  
Lumpy Skin Disease ◽  
Cattle Disease ◽  
Outbreak Area ◽  
Steroid Drugs ◽  
First Time

Lumpy skin disease is explained as a significant cattle disease affecting cattle of many parts of the world. An outbreak was experienced in different parts of Bangladesh including Barishal for the first time in the last quarter of 2019. This investigation was carried out to know the outbreak scenario of the disease in southern part of Bangladesh. A total of 726 cattle were included in this study covering 50 dairy farms of Barishal region from September 2019 to December 2019. Morbidity rate was found 21% (CI: 18-24%) and mortality was 1% (CI: 1-2%) in the outbreak area. Young animals (24%) and pregnant animals (70%) were significantly more susceptible compared to aged animals (17%) and non-pregnant animals (15%), respectively. Moreover, male and crossbred cattle were slightly more prone to the infection in comparison to their counterparts. About 45% of the affected animals showed nodular and remaining 55% had edematous lesions. Almost 90% of the affected animals were treated with NSAID followed by antibiotics, antihistaminic, steroid drugs and antiviral drugs where only 20% of the affected animals were treated by authorized veterinary personnel. This was the first epidemiological investigation in the mentioned outbreak area which may serve as a baseline for LSD research in the location needed for developing effective control strategy.

Outbreak investigation and molecular diagnosis of Lumpy skin disease among livestock in Saudi Arabia 2016

2017 ◽  
Vol 65 (2) ◽  
pp. e494-e500 ◽  
Author(s):  
S. Kasem ◽  
M. Saleh ◽  
I. Qasim ◽  
O. Hashim ◽  
A. Alkarar ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Molecular Diagnosis ◽  
Skin Disease ◽  
Outbreak Investigation ◽  
Lumpy Skin Disease

scholarly journals Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines

Vaccines ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 473
Author(s):  
Andy Haegeman ◽  
Ilse De Leeuw ◽  
Laurent Mostin ◽  
Willem Van Campe ◽  
Laetitia Aerts ◽  
...  
Keyword(s):  
Disease Virus ◽  
Skin Disease ◽  
Vaccination Campaign ◽  
Ease Of Use ◽  
Vaccine Failure ◽  
Lumpy Skin Disease ◽  
Lumpy Skin Disease Virus ◽  
The Balkans ◽  
The Past ◽  
Preventative Strategy

Vaccines form the cornerstone of any control, eradication and preventative strategy and this is no different for lumpy skin disease. However, the usefulness of a vaccine is determined by a multiplicity of factors which include stability, efficiency, safety and ease of use, to name a few. Although the vaccination campaign in the Balkans against lumpy skin disease virus (LSDV) was successful and has been implemented with success in the past in other countries, data of vaccine failure have also been reported. It was therefore the purpose of this study to compare five homologous live attenuated LSDV vaccines (LSDV LAV) in a standardized setting. All five LSDV LAVs studied were able to protect against a challenge with virulent LSDV. Aside from small differences in serological responses, important differences were seen in side effects such as a local reaction and a Neethling response upon vaccination between the analyzed vaccines. These observations can have important implications in the applicability in the field for some of these LSDV LAVs.

scholarly journals Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus

Vaccines ◽  
2020 ◽  
Vol 9 (1) ◽  
pp. 4
Author(s):  
Janika Wolff ◽  
Tom Moritz ◽  
Kore Schlottau ◽  
Donata Hoffmann ◽  
Martin Beer ◽  
...  
Keyword(s):  
Skin Disease ◽  
Animal Health ◽  
Vaccine Virus ◽  
Lumpy Skin Disease ◽  
Virus Shedding ◽  
Clinical Protection ◽  
Inactivated Vaccines ◽  
Disease Free ◽  
World Organisation ◽  
Free Status

Capripox virus (CaPV)-induced diseases (lumpy skin disease, sheeppox, goatpox) are described as the most serious pox diseases of livestock animals, and therefore are listed as notifiable diseases under guidelines of the World Organisation for Animal Health (OIE). Until now, only live-attenuated vaccines are commercially available for the control of CaPV. Due to numerous potential problems after vaccination (e.g., loss of the disease-free status of the respective country, the possibility of vaccine virus shedding and transmission as well as the risk of recombination with field strains during natural outbreaks), the use of these vaccines must be considered carefully and is not recommended in CaPV-free countries. Therefore, innocuous and efficacious inactivated vaccines against CaPV would provide a great tool for control of these diseases. Unfortunately, most inactivated Capripox vaccines were reported as insufficient and protection seemed to be only short-lived. Nevertheless, a few studies dealing with inactivated vaccines against CaPV are published, giving evidence for good clinical protection against CaPV-infections. In our studies, a low molecular weight copolymer-adjuvanted vaccine formulation was able to induce sterile immunity in the respective animals after severe challenge infection. Our findings strongly support the possibility of useful inactivated vaccines against CaPV-infections, and indicate a marked impact of the chosen adjuvant for the level of protection.

Sign in / Sign up

Export Citation Format

Share Document